GDF 15-a novel biomarker in the offing for heart failure M George, A Jena, V Srivatsan, R Muthukumar, VE Dhandapani Current cardiology reviews 12 (1), 37-46, 2016 | 100 | 2016 |
New and emerging drug molecules against obesity M George, M Rajaram, E Shanmugam Journal of cardiovascular pharmacology and therapeutics 19 (1), 65-76, 2014 | 97 | 2014 |
The dawn of hedgehog inhibitors: Vismodegib S Sandhiya, G Melvin, SS Kumar, SA Dkhar Journal of Pharmacology and Pharmacotherapeutics 4 (1), 4-7, 2013 | 93 | 2013 |
Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand? V Srivatsan, M George, E Shanmugam European journal of preventive cardiology 22 (9), 1096-1110, 2015 | 74 | 2015 |
The LCR-like α-globin positive regulatory element functions as an enhancer in transiently transfected cells during erythroid differentiation MD Pondel, M George, NJ Proudfoot Nucleic acids research 20 (2), 237-243, 1992 | 50 | 1992 |
A peek into the drug development scenario of endometriosis–A systematic review L Goenka, M George, M Sen Biomedicine & Pharmacotherapy 90, 575-585, 2017 | 45 | 2017 |
Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study M George, E Shanmugam, V Srivatsan, K Vasanth, B Ramraj, M Rajaram, ... Therapeutic advances in cardiovascular disease 9 (5), 275-284, 2015 | 45 | 2015 |
Novel drug targets in clinical development for heart failure M George, M Rajaram, E Shanmugam, TM VijayaKumar European journal of clinical pharmacology 70, 765-774, 2014 | 37 | 2014 |
Newer antipsychotics and upcoming molecules for schizophrenia M George, R Amrutheshwar, RP Rajkumar, S Kattimani, SA Dkhar European journal of clinical pharmacology 69, 1497-1509, 2013 | 35 | 2013 |
TEVAR for complicated and uncomplicated type B aortic dissection—systematic review and meta‐analysis C Howard, J Sheridan, L Picca, S Reza, T Smith, A Ponnapalli, R Calow, ... Journal of cardiac surgery 36 (10), 3820-3830, 2021 | 34 | 2021 |
Neuroprotective agents in acute ischemic stroke—a reality check L Goenka, CRU Satyanarayana, M George Biomedicine & Pharmacotherapy 109, 2539-2547, 2019 | 34 | 2019 |
Prognostic role of soluble ST 2 in acute coronary syndrome with diabetes D Jha, L Goenka, T Ramamoorthy, M Sharma, VE Dhandapani, M George European Journal of Clinical Investigation 48 (9), e12994, 2018 | 34 | 2018 |
Pattern of adverse drug reactions reported with cardiovascular drugs in a tertiary care teaching hospital M Palaniappan, S Selvarajan, M George, G Subramaniyan, SA Dkhar, ... Journal of clinical and diagnostic research: JCDR 9 (11), FC01, 2015 | 32 | 2015 |
Effect of tolvaptan on acute heart failure with hyponatremia–a randomized, double blind, controlled clinical trial E Shanmugam, CRMP Doss, M George, A Jena, M Rajaram, B Ramaraj, ... Indian heart journal 68, S15-S21, 2016 | 30 | 2016 |
Evaluation of endothelial and platelet derived microparticles in patients with acute coronary syndrome M George, MR Ganesh, A Sridhar, A Jena, M Rajaram, E Shanmugam, ... Journal of clinical and diagnostic research: JCDR 9 (12), OC09, 2015 | 30 | 2015 |
Cancer biomarkers: minimal and noninvasive early diagnosis and prognosis D Barh, A Carpi, M Verma, M Gunduz CRC Press, 2014 | 29 | 2014 |
Comparison of ranolazine and trimetazidine on glycemic status in diabetic patients with coronary artery disease–A randomized controlled trial S Sandhiya, SA Dkhar, AA Pillai, M George, B Jayaraman, ... Journal of clinical and diagnostic research: JCDR 9 (1), OC01, 2015 | 27 | 2015 |
Globalization of clinical trials–where are we heading? M George, S Selvarajan, S A Dkhar, A Chandrasekaran Current clinical pharmacology 8 (2), 115-123, 2013 | 26 | 2013 |
Pharmacovigilance for psychiatrists: An introduction RP Rajkumar, G Melvin Indian journal of psychiatry 56 (2), 176-181, 2014 | 23 | 2014 |
Can mRNA vaccines turn the tables during the COVID-19 pandemic? Current status and challenges DP Sagili Anthony, K Sivakumar, P Venugopal, DK Sriram, M George Clinical drug investigation 41, 499-509, 2021 | 22 | 2021 |